Cell-Free Reporter Complex for TRID Mechanism Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for developing translation readthrough inducers (TRIDs) are hindered by a lack of understanding of their precise mechanisms of action, limiting the identification of new, clinically useful TRIDs for treating diseases caused by premature stop codons.
Innovation Solution
A system comprising a cell-free ribosome-dependent protein synthesis reporter complex with labeled tRNA and modified RNA molecules, allowing for the detection of TRIDs through fluorescence anisotropy measurements, which distinguishes direct and indirect acting TRIDs and identifies potential TRIDs for specific disease contexts.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If traditional in vitro, ex vivo, or in vivo experiments are used to identify TRIDs, then a diverse structural set of TRIDs can be identified, but the precise mechanisms of action cannot be determined due to multiple possible mechanisms (direct binding to protein synthesis machinery, indirect inhibition of nonsense-mediated mRNA decay, or modulation of cellular activity levels)
Solution Approach 1:
The invention segments the complex cellular environment into isolated, controlled in vitro systems using purified components (ribosomes, tRNAs, mRNA, and TRIDs). This segmentation allows each component's interaction to be studied independently, enabling precise determination of whether TRIDs act directly on the protein synthesis machinery or through indirect mechanisms.
Solution Approach 2:
The invention introduces fluorescently labeled near-cognate tRNAs as intermediaries to detect TRID action. By monitoring the selection and incorporation of these labeled tRNAs at PTC positions, the system provides direct evidence of readthrough induction mechanisms, resolving the ambiguity of direct versus indirect action.
2Reliability
If animal or intact cell systems are used to measure TRID-induced readthrough, then readthrough activity can be detected, but the complexity of the system prevents rational design of new TRIDs
Solution Approach 1:
The invention extracts the essential readthrough mechanism from complex animal or cell systems by using purified in vitro components. This extraction maintains the core readthrough activity while removing confounding variables, enabling both reliable detection and rational drug design through simplified, controllable experiments.
Solution Approach 2:
The invention changes the experimental parameters from whole-cell or animal systems to purified biochemical systems with controlled variables. By adjusting parameters such as component concentrations, TRID doses, and fluorescent labels, the system achieves reliable readthrough detection while maintaining simplicity for rational design.
3Productivity
If crude cell extracts are used to study TRID mechanisms, then readthrough can be observed, but the multiplicity of mechanisms complicates determination of precise molecular interactions
Solution Approach 1:
The invention creates a simplified copy of the cellular protein synthesis system using purified components that replicate essential functions. This copy system maintains readthrough productivity while enabling precise detection of molecular interactions through controlled variables and fluorescent labeling, overcoming the measurement difficulties of crude extracts.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables high-throughput detection and characterization of TRIDs, facilitating the identification of effective compounds for treating diseases with premature stop codons by providing insights into their mechanisms of action and therapeutic potential.
Implementation Method 1
one or more amino acids of the peptide are labeled with a fluorophore or a chromophore, or a transfer-ribonucleic acid linked to a fluorophore or a chromophore (labeled-tRNA)
Data Source
AI summary
Disclosed are systems and methods for high throughput screening to detect translation readthrough induced drugs (TRID). The systems use highly purified, eukaryotic cell-free protein synthesis systems that distinguish TRIDs acting directly on the protein synthesis machinery from those that act indirectly.